PE/Cyanine7 anti-mouse CD19 Antibody
- 产品名称：
- PE/Cyanine7 anti-mouse CD19 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 115519
- 产品应用：
- 115519
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- Mouse CD19-expressing K562 human erythroleukemia cells
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
Additional reported applications (for the relevant formats) include: immunofluorescence7.
- Additional Product Notes
- BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Shoham T, et al. 2003. J. Immunol. 171:4062. (FC)
- Goodyear CS, et al. 2004. J. Immunol. 172:2870. (FC)
- Kamimura D, et al. 2006. J. Immunol. 177:306. (FC)
- Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (FC)
- Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC)
- Phan TG, et al. 2007. Nat. Immunol. 8:992. (FC)
- Hayashida K, et al. 2008. J. Biol. Chem. 283:19895. (IF) PubMed
- Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
- Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
- Stadnisky MD, et al. 2011. Blood. 117:5133. (FC) PubMed
- Perlot T, et al. 2012. J. Immunol. 188:1201. (FC) PubMed
- Olive V, et al. 2013. Elife. 2:822. PubMed
- Miyai T, et al. 2014. PNAS. 111:11780. PubMed
- Product Citations
-
- Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
- Zhu Y, et al. 2022. Nat Commun. 13:4282. PubMed
- Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
- Barrett N, et al. 2016. Cell Rep. 16: 1039-1054. PubMed
- Bussières-Marmen S, et al. 2017. Cell Mol Immunol. 10.1038/cmi.2016.72. PubMed
- Turecamo SE, et al. 2018. Matrix Biol. 67:01:00. PubMed
- Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
- Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
- d'Errico P, et al. 2021. Nat Neurosci. Online ahead of print. PubMed
- Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
- Clark K, et al. 2015. J Autoimmun. Available online 21 August 2015. PubMed
- Casta?eda-Zegarra S, et al. 2020. Aging (Albany NY). 12:00. PubMed
- Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
- Yang C, et al. 2020. J Control Release. 326:324. PubMed
- Lin CA, et al. 2021. Pharmaceutics. 13:. PubMed
- Morgado P, et al. 2014. Infect Immun . 82:4047. PubMed
- Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
- Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
- Liao Y, et al. 2017. Virol J. 10.1186/s12985-017-0801-x. PubMed
- Alberti D, et al. 2021. Curr Protoc. 1:e311. PubMed
- Rogawski DS, et al. 2021. Nat Commun. 12:2792. PubMed
- Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
- Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
- Haugh KA, et al. 2021. eLife. 0.416666666666667. PubMed
- Campana L, et al. 2018. J Immunol. 200:1169. PubMed
- Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
- Yoshida K, et al. 2022. Sci Rep. 12:17276. PubMed
- Wiesner D, et al. 2015. PLoS Pathog. 11:1004701. PubMed
- Syed A, et al. 2015. Infect Immun . 83: 3428-3437. PubMed
- Uchil PD et al. 2018. Cell host & microbe. 25(1):87-100 . PubMed
- Schaffert A, et al. 2020. Front Immunol. 10:3024. PubMed
- Calés C, et al. 2016. Mol Cell Biol. 36: 900 - 912. PubMed
- JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
- Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
- Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
- Pereira JA, et al. 2020. Hum Mol Genet. 29:1253. PubMed
- , et al. 2021. Eur J Immunol. 51:2708. PubMed
- Siggs O, et al. 2015. Proc Natl Acad Sci U S A. 112: E5706 - E5714. PubMed
- Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
- Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
- Malik A et al. 2018. Immunity. 49(3):515-530 . PubMed
- Noviski M, et al. 2018. Elife. 7:e35074. PubMed
- Zhang H, et al. 2019. Mol Cell. 76:110. PubMed
- Kr?utler NJ, et al. 2020. Cell Reports. 30(4):997-1012.e6.. PubMed
- Wu S, et al. 2022. BMC Immunol. 23:17. PubMed
- Kang X, et al. 2022. J Immunol Res. 2022:8118577. PubMed
- Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed
- Pillonel V, et al. 2016. Sci Rep. 6:37772. PubMed
- Lim S, et al. 2016. PLoS One. 11: 0155689. PubMed
- Challa TD, et al. 2020. Cell Reports. 30(10):3424-3433. PubMed
- Wang YH, et al. 2019. Front Immunol. 10:1909. PubMed
- Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
- Shiozawa S, et al. 2022. iScience. 25:103537. PubMed
- Ma K, et al. 2022. iScience. 25:104347. PubMed
- Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
- Kim MY, et al. 2018. Cell. 173:1439. PubMed
- Matthew B Buechler et al. 2019. Immunity. 51(1):119-130 . PubMed
- Li M, et al. 2021. Cancers (Basel). 13:. PubMed
- Wieghofer P, et al. 2021. EMBO J. 40:e105123. PubMed
- Lehrke MJ, et al. 2021. Elife. 10:. PubMed
- Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
- Zhou X, et al. 2021. Cell Reports. 34(1):108601. PubMed
- Haniuda K, et al. 2020. Cell Rep. 33:108333. PubMed
- Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
- Andersen TK, et al. 2019. NPJ Vaccines. 4:9. PubMed
- Ackermann C, et al. 2019. Sci Rep. 9:10624. PubMed
- Willemsen J, et al. 2021. Cell Rep. 37:109977. PubMed
- Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
- Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
- Vincent B, et al. 2010. J Immunol. 184:4196. PubMed
- Ghezraoui H, et al. 2018. Nature. 560:122. PubMed
- Korin B, et al. 2020. Sleep. :43. PubMed
- Shimba A et al. 2018. Immunity. 48(2):286-298 . PubMed
- Zhang Y, et al. 2022. Front Pharmacol. 13:952775. PubMed
- Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
- Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
- Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
- Parigger T, et al. 2021. Int J Mol Sci. 22:. PubMed
- Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
- Bansal K, et al. 2017. Nat Immunol. 18:263-273. PubMed
- Leruste A, et al. 2020. Cancer Cell. 36(6):597-612.e8.. PubMed
- Song W, et al. 2022. Immunity. 55:290. PubMed
- Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
- Kleiman E, et al. 2016. Proc Natl Acad Sci U S A. 113: E3911 - E3920. PubMed
- Fusciello M, et al. 2019. Nat Commun. 4.407638889. PubMed
- Huang LH et al. 2018. Cell metabolism. 29(2):475-487 . PubMed
- RRID
- AB_313654 (BioLegend Cat. No. 115519) AB_313655 (BioLegend Cat. No. 115520)
- Structure
- Ig superfamily, associates with CD21 and CD81, 95 kD
- Distribution
-
Pro-B cells to mature B cells (during development), follicular dendritic cells
- Function
- Modulates B cell activation and differentiation
- Ligand/Receptor
- CD21, CD81, Leu-13
- Cell Type
- B cells, Dendritic cells
- Biology Area
- Costimulatory Molecules, Immunology
- Molecular Family
- CD Molecules
- Antigen References
-
1. Fearon DT. 1993. Curr. Opin. Immunol. 5:341.
2. Krop I, et al. 1996. Eur. J. Immunol. 26:238.
3. Krop I, et al. 1996. J. Immunol. 157:48.
4. Tedder TF, et al. 1994. Immunol. Today 15:437.
- Gene ID
- 12478 View all products for this Gene ID
- UniProt
- View information about CD19 on UniProt.org
